Skip to main content
Fig. 5 | The Journal of Headache and Pain

Fig. 5

From: Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis

Fig. 5

Changes of migraine type and MO/MOH after initial response to CGRP (receptor) antibody therapy. Migraine type and MO/MOH after three months of therapy and at the LOTP (CM-MOH: chronic migraine with medication overuse headache, CM-noMOH: chronic migraine without medication overuse headache, EM-MO: Episodic migraine with medication overuse, EM-noMO: Episodic migraine without medication overuse, LOTP: last observation time point)

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us